Fluticasone propionate + Salmeterol xinafoate Inhaler is indicated in the regular treatment of asthma where use of a combination (long acting beta-2 agonist and inhaled corticosteroid) is appropriate: Patients not adequately controlled with inhaled corticosteroids and "as needed" inhaled short acting beta-2 agonist or; patients already adequately controlled on both inhaled corticosteroids and long acting beta-2 agonist.